Arlo Technologies Form 144 reveals $26.8M insider share sale plan

Rhea-AI Filing Summary

The Form 144 filing discloses a proposed insider sale of Arlo Technologies, Inc. (symbol ARLO) common stock. According to the submission, 1,554,871 shares are slated for sale through Morgan Stanley Smith Barney on or about 20 June 2025. Based on the filing’s stated aggregate market value of $26.79 million, the planned disposition equals roughly 1.5 % of the company’s 103,400,957 shares outstanding. The shares derive primarily from Restricted Stock Units and Performance Stock Units granted on 31 October 2019 (1,523,286 shares) and from an Employee Stock Purchase Plan purchase on 15 August 2019 (31,585 shares).

The selling shareholder, identified in the past-sale table as Matthew B. McRae, has already sold 117,404 shares over the last three months for total gross proceeds of $1.21 million. The current notice notes no material adverse information known to the seller and is filed under Rule 144, indicating adherence to SEC resale requirements. Nonetheless, the scale and continued pattern of insider selling may be interpreted by investors as a potential overhang on the stock and a signal of diminished insider conviction.

Positive

• None.

Negative

• 1,554,871-share proposed sale (~1.5 % of shares outstanding) may exert downward supply pressure on ARLO stock.
• Ongoing insider selling pattern (117 k shares already sold in prior 3 months) could signal low insider confidence.

Insights

Securities Analyst

TL;DR – Insider plans 1.55 M-share sale (~1.5 % float); likely modestly bearish supply signal.

The filing signals that 1,554,871 Arlo shares valued at $26.8 million could hit the market around 20 June 2025. Combined with 117 k shares already sold since late April, the insider’s cumulative disposition approaches 1.7 million shares. At ~1.5 % of outstanding stock, the transaction is large enough to create short-term selling pressure and may dampen sentiment, especially given the absence of offsetting corporate developments such as buybacks or positive earnings data in the filing. Because the shares stem from equity compensation, taxation and diversification motives are possible, but the market typically views sizable insider liquidation as a negative indicator of expected near-term performance.

Corporate Governance Expert

TL;DR – Rule 144 notice meets disclosure rules; continuous sales could raise governance-related perception risks.

From a governance standpoint, the filer is complying with Rule 144 transparency, detailing acquisition dates, consideration and broker arrangements. However, the absence of a disclosed 10b5-1 adoption date limits clarity on whether the sale is pre-programmed or discretionary. Repeated insider sales within a short window can be scrutinized by shareholders, potentially prompting calls for clearer alignment mechanisms or updated compensation structures to mitigate dilution concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1554871	26790427.33	103400957	06/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/31/2019	Restricted Stock Units & Performance Stock Units	Issuer			1523286	10/31/2019	N/A
Common	08/15/2019	Employee Stock Purchase Plan	Issuer			31585	08/15/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MATTHEW B MCRAE 5770 Fleet Street Carlsbad CA 92008	Common	05/08/2025	91999	954195.23
MATTHEW B MCRAE 5770 Fleet Street Carlsbad CA 92008	Common	04/28/2025	25405	251506.96

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Arlo (ARLO) shares are proposed for sale under the current Form 144?

The notice covers 1,554,871 common shares.

What is the aggregate market value of the planned insider sale?

The filing lists an aggregate market value of $26,790,427.33.

What percentage of Arlo’s shares outstanding does the sale represent?

It represents approximately 1.5 % of the 103,400,957 shares outstanding.

When is the approximate sale date for the shares?

The seller indicates an approximate sale date of 20 June 2025.

Has the insider sold Arlo shares recently?

Yes. The same seller disposed of 117,404 shares between 28 April 2025 and 8 May 2025, garnering $1.21 million in gross proceeds.

Which broker is handling the proposed transaction?

Morgan Stanley Smith Barney LLC, Executive Financial Services, is listed as broker.